Drug
Ertapenem
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Macular Degeneration | 778 | 359.9 | 444.7 | signal |
| 2 | Vaginal Discharge | 163 | 84.9 | 88.4 | signal |
| 3 | Paraesthesia Oral | 214 | 77.8 | 82.1 | signal |
| 4 | Oral Candidiasis | 170 | 68.2 | 71.1 | signal |
| 5 | Clostridium Difficile Colitis | 81 | 39.6 | 40.4 | signal |
| 6 | Procedural Pain | 194 | 36.4 | 38.1 | signal |
| 7 | Frequent Bowel Movements | 165 | 31.8 | 33.1 | signal |
| 8 | Encephalopathy | 124 | 26.2 | 27.0 | signal |
| 9 | Colitis | 170 | 23.3 | 24.3 | signal |
| 10 | Rectal Haemorrhage | 166 | 19.9 | 20.7 | signal |
| 11 | Neurotoxicity | 66 | 19.6 | 19.9 | signal |
| 12 | Colitis Ulcerative | 165 | 19.1 | 19.9 | signal |
| 13 | Clostridium Difficile Infection | 76 | 18.1 | 18.4 | signal |
| 14 | Status Epilepticus | 37 | 16.9 | 17.0 | signal |
| 15 | Drug Resistance | 83 | 16.7 | 17.0 | signal |
| 16 | Infusion Related Reaction | 213 | 16.7 | 17.5 | signal |
| 17 | Therapeutic Product Effect Incomplete | 223 | 16.3 | 17.2 | signal |
| 18 | Haematochezia | 169 | 15.8 | 16.5 | signal |
| 19 | Myoclonus | 36 | 15.6 | 15.7 | signal |
| 20 | Drug Reaction With Eosinophilia And Systemic Symptoms | 69 | 13.9 | 14.2 | signal |
| 21 | Generalised Tonic-clonic Seizure | 39 | 12.3 | 12.4 | signal |
| 22 | Eosinophilia | 41 | 12.1 | 12.2 | signal |
| 23 | Nephropathy Toxic | 26 | 12.0 | 12.1 | signal |
| 24 | Urosepsis | 21 | 11.8 | 11.8 | signal |
| 25 | Hallucination, Visual | 47 | 11.6 | 11.7 | signal |
| 26 | Renal Tubular Necrosis | 21 | 11.0 | 11.1 | signal |
| 27 | Mental Status Changes | 57 | 10.6 | 10.7 | signal |
| 28 | Dyspepsia | 197 | 10.4 | 10.8 | signal |
| 29 | Epilepsy | 61 | 10.3 | 10.5 | signal |
| 30 | Erythema Multiforme | 17 | 9.4 | 9.4 | signal |
| 31 | Posterior Reversible Encephalopathy Syndrome | 17 | 9.2 | 9.2 | signal |
| 32 | Serotonin Syndrome | 34 | 9.2 | 9.2 | signal |
| 33 | Drug Level Increased | 28 | 8.7 | 8.8 | signal |
| 34 | Coagulopathy | 27 | 8.4 | 8.4 | signal |
| 35 | Bacteraemia | 19 | 8.3 | 8.4 | signal |
| 36 | Delirium | 54 | 8.1 | 8.1 | signal |
| 37 | Malnutrition | 17 | 7.9 | 7.9 | signal |
| 38 | Metabolic Acidosis | 47 | 7.7 | 7.7 | signal |
| 39 | Bone Marrow Failure | 30 | 7.6 | 7.6 | signal |
| 40 | Scar | 25 | 7.5 | 7.6 | signal |
| 41 | Hepatocellular Injury | 20 | 7.3 | 7.3 | signal |
| 42 | Hallucination | 102 | 7.0 | 7.2 | signal |
| 43 | Osteomyelitis | 24 | 6.8 | 6.9 | signal |
| 44 | Muscle Spasticity | 16 | 6.7 | 6.7 | signal |
| 45 | Subarachnoid Haemorrhage | 13 | 6.6 | 6.6 | signal |
| 46 | Septic Shock | 51 | 6.1 | 6.1 | signal |
| 47 | Confusional State | 191 | 6.1 | 6.3 | signal |
| 48 | Anaemia | 225 | 6.1 | 6.4 | signal |
| 49 | Drug-induced Liver Injury | 36 | 6.0 | 6.1 | signal |
| 50 | Fistula | 13 | 5.9 | 6.0 | signal |
| 51 | Lymphopenia | 16 | 5.9 | 5.9 | signal |
| 52 | Toxic Epidermal Necrolysis | 17 | 5.8 | 5.8 | signal |
| 53 | Tubulointerstitial Nephritis | 21 | 5.8 | 5.8 | signal |
| 54 | Leukocytosis | 20 | 5.7 | 5.7 | signal |
| 55 | Device Related Infection | 17 | 5.7 | 5.7 | signal |
| 56 | Hypomagnesaemia | 15 | 5.6 | 5.6 | signal |
| 57 | Hyperbilirubinaemia | 11 | 5.5 | 5.5 | signal |
| 58 | Small Intestinal Obstruction | 13 | 5.5 | 5.5 | signal |
| 59 | Pyrexia | 366 | 5.4 | 5.9 | signal |
| 60 | Seizure | 117 | 5.3 | 5.4 | signal |
| 61 | Skin Lesion | 26 | 4.9 | 4.9 | signal |
| 62 | Sepsis | 106 | 4.9 | 5.0 | signal |
| 63 | Multiple Organ Dysfunction Syndrome | 26 | 4.8 | 4.8 | signal |
| 64 | Dysarthria | 35 | 4.8 | 4.8 | signal |
| 65 | Rash Maculo-papular | 20 | 4.7 | 4.7 | signal |
| 66 | Abdominal Pain | 209 | 4.6 | 4.8 | signal |
| 67 | Weight Decreased | 250 | 4.6 | 4.9 | signal |
| 68 | Blood Bilirubin Increased | 24 | 4.6 | 4.6 | signal |
| 69 | Cyst | 11 | 4.6 | 4.6 | signal |
| 70 | Lactic Acidosis | 28 | 4.5 | 4.5 | signal |
| 71 | Erythema | 178 | 4.5 | 4.6 | signal |
| 72 | Rhabdomyolysis | 36 | 4.5 | 4.5 | signal |
| 73 | Bacterial Infection | 16 | 4.4 | 4.5 | signal |
| 74 | Constipation | 186 | 4.4 | 4.6 | signal |
| 75 | Cytokine Release Syndrome | 16 | 4.3 | 4.3 | signal |
| 76 | Drug Interaction | 133 | 4.3 | 4.4 | signal |
| 77 | Respiratory Distress | 23 | 4.3 | 4.3 | signal |
| 78 | White Blood Cell Count Increased | 32 | 4.3 | 4.3 | signal |
| 79 | Vitamin D Deficiency | 8 | 4.2 | 4.2 | signal |
| 80 | Pneumocystis Jirovecii Pneumonia | 8 | 4.1 | 4.1 | signal |
| 81 | Hypocalcaemia | 15 | 4.1 | 4.1 | signal |
| 82 | Hepatitis | 20 | 4.0 | 4.0 | signal |
| 83 | Drug Ineffective | 1,024 | 4.0 | 5.0 | signal |
| 84 | Unresponsive To Stimuli | 20 | 4.0 | 4.0 | signal |
| 85 | Stevens-johnson Syndrome | 17 | 3.9 | 3.9 | signal |
| 86 | Pancreatitis Acute | 17 | 3.9 | 3.9 | signal |
| 87 | Abscess | 12 | 3.9 | 3.9 | signal |
| 88 | Thrombocytopenia | 83 | 3.8 | 3.9 | signal |
| 89 | Multi-organ Failure | 13 | 3.8 | 3.8 | signal |
| 90 | Acute Respiratory Distress Syndrome | 13 | 3.8 | 3.8 | signal |
| 91 | Depressed Level Of Consciousness | 29 | 3.8 | 3.8 | signal |
| 92 | Cytomegalovirus Infection | 12 | 3.7 | 3.7 | signal |
| 93 | Pancreatitis | 38 | 3.7 | 3.7 | signal |
| 94 | Intestinal Perforation | 8 | 3.7 | 3.7 | signal |
| 95 | Hepatomegaly | 7 | 3.7 | 3.7 | signal |
| 96 | Treatment Failure | 58 | 3.6 | 3.7 | signal |
| 97 | Staphylococcal Infection | 23 | 3.6 | 3.6 | signal |
| 98 | Nodule | 9 | 3.6 | 3.6 | signal |
| 99 | Acute Kidney Injury | 105 | 3.6 | 3.6 | signal |
| 100 | Neutropenia | 93 | 3.5 | 3.6 | signal |
| 101 | Drug Level Decreased | 7 | 3.5 | 3.5 | signal |
| 102 | Acute Respiratory Failure | 13 | 3.5 | 3.5 | signal |
| 103 | Psychomotor Hyperactivity | 11 | 3.4 | 3.4 | signal |
| 104 | Hypoxia | 23 | 3.4 | 3.4 | signal |
| 105 | Disorientation | 26 | 3.4 | 3.4 | signal |
| 106 | Aspiration | 7 | 3.3 | 3.3 | signal |
| 107 | Dystonia | 12 | 3.2 | 3.2 | signal |
| 108 | Candida Infection | 10 | 3.1 | 3.1 | signal |
| 109 | Toxic Skin Eruption | 6 | 3.1 | 3.1 | signal |
| 110 | Neutrophil Count Increased | 6 | 3.0 | 3.0 | signal |
| 111 | Hypoglycaemia | 28 | 3.0 | 3.0 | signal |
| 112 | Hepatic Cytolysis | 7 | 3.0 | 3.0 | signal |
| 113 | Fungal Infection | 19 | 2.9 | 2.9 | signal |
| 114 | Shock | 13 | 2.9 | 2.9 | signal |
| 115 | Drug Eruption | 10 | 2.9 | 2.9 | signal |
| 116 | Hallucination, Auditory | 9 | 2.9 | 2.9 | signal |
| 117 | Product Use In Unapproved Indication | 133 | 2.8 | 2.9 | signal |
| 118 | Hyperkalaemia | 19 | 2.8 | 2.8 | signal |
| 119 | Hepatotoxicity | 12 | 2.8 | 2.8 | signal |
| 120 | Haematotoxicity | 5 | 2.8 | 2.8 | signal |
| 121 | Liver Injury | 13 | 2.8 | 2.8 | signal |
| 122 | Hepatic Encephalopathy | 5 | 2.8 | 2.8 | no signal |
| 123 | Grand Mal Convulsion | 5 | 2.7 | 2.8 | no signal |
| 124 | Cerebral Haemorrhage | 19 | 2.7 | 2.7 | signal |
| 125 | Malaise | 233 | 2.7 | 2.8 | signal |
| 126 | Agitation | 39 | 2.7 | 2.7 | signal |
| 127 | Hepatic Failure | 16 | 2.7 | 2.7 | signal |
| 128 | Dermatitis Contact | 6 | 2.7 | 2.7 | signal |
| 129 | Parkinsonism | 5 | 2.6 | 2.6 | no signal |
| 130 | Splenomegaly | 6 | 2.6 | 2.6 | signal |
| 131 | Urinary Tract Infection | 87 | 2.6 | 2.7 | signal |
| 132 | Neuroleptic Malignant Syndrome | 6 | 2.6 | 2.6 | signal |
| 133 | Convulsion | 29 | 2.6 | 2.6 | signal |
| 134 | Localised Infection | 12 | 2.6 | 2.6 | signal |
| 135 | Rash Erythematous | 23 | 2.5 | 2.5 | signal |
| 136 | Rash Papular | 11 | 2.5 | 2.5 | signal |
| 137 | Mobility Decreased | 34 | 2.4 | 2.5 | signal |
| 138 | Renal Pain | 5 | 2.4 | 2.4 | no signal |
| 139 | Gastric Ulcer | 9 | 2.4 | 2.4 | signal |
| 140 | Off Label Use | 410 | 2.4 | 2.6 | signal |
| 141 | Cholestasis | 9 | 2.4 | 2.4 | signal |
| 142 | Pain | 289 | 2.4 | 2.5 | signal |
| 143 | Altered State Of Consciousness | 10 | 2.4 | 2.4 | signal |
| 144 | Quality Of Life Decreased | 6 | 2.3 | 2.3 | no signal |
| 145 | Blood Creatine Phosphokinase Increased | 13 | 2.3 | 2.3 | signal |
| 146 | Product Prescribing Issue | 9 | 2.3 | 2.3 | signal |
| 147 | Renal Failure Acute | 19 | 2.3 | 2.3 | signal |
| 148 | Leukopenia | 22 | 2.3 | 2.3 | signal |
| 149 | Febrile Neutropenia | 29 | 2.3 | 2.3 | signal |
| 150 | Pancytopenia | 24 | 2.2 | 2.2 | signal |
| 151 | Angioedema | 19 | 2.2 | 2.2 | signal |
| 152 | Proteinuria | 8 | 2.2 | 2.2 | signal |
| 153 | Muscle Rigidity | 5 | 2.2 | 2.2 | no signal |
| 154 | Upper Gastrointestinal Haemorrhage | 7 | 2.1 | 2.1 | no signal |
| 155 | Mental Disorder | 18 | 2.1 | 2.1 | signal |
| 156 | Peritonitis | 8 | 2.0 | 2.0 | no signal |
| 157 | Acute Hepatic Failure | 5 | 1.9 | 1.9 | no signal |
| 158 | Myocarditis | 4 | 1.8 | 1.8 | no signal |
| 159 | Deformity | 3 | 1.6 | 1.6 | no signal |
| 160 | Tardive Dyskinesia | 9 | 1.6 | 1.6 | no signal |
| 161 | Premature Delivery | 5 | 1.6 | 1.6 | no signal |
| 162 | Mania | 5 | 1.6 | 1.6 | no signal |
| 163 | Toxicity To Various Agents | 51 | 1.6 | 1.6 | no signal |
| 164 | Sopor | 4 | 1.5 | 1.5 | no signal |
| 165 | Peritonitis Bacterial | 3 | 1.5 | 1.5 | no signal |
| 166 | Myelosuppression | 10 | 1.5 | 1.5 | no signal |
| 167 | Blindness Unilateral | 4 | 1.5 | 1.5 | no signal |
| 168 | Sedation | 7 | 1.4 | 1.4 | no signal |
| 169 | Rebound Effect | 3 | 1.4 | 1.4 | no signal |
| 170 | Palmar-plantar Erythrodysaesthesia Syndrome | 6 | 1.3 | 1.3 | no signal |
| 171 | Suicidal Ideation | 23 | 1.3 | 1.3 | no signal |
| 172 | Osteonecrosis Of Jaw | 6 | 1.2 | 1.2 | no signal |
| 173 | Product Preparation Error | 4 | 1.0 | 1.0 | no signal |
| 174 | Colorectal Cancer | 5 | 0.5 | 0.5 | no signal |